Diagnostic and Interventional Cardiology

News | Coronavirus (COVID-19)

International Multi-center Study Confirms Stroke Risk in Younger Healthier COVID-19 Patients

April 1, 2022 – Over the course of the pandemic, a number of studies examined whether COVID-19 patients were at ...

March 31, 2022

Stereotaxis’ Genesis Robotic Magnetic Navigation (RMN) system

News | Robotic Systems

National Institute of Cardiology Becomes First Hospital in Poland to Establish Advanced Robotic Program to Treat Heart Rhythm Disorders

April 1, 2022 – Stereotaxis, the global leader in innovative robotic technologies for the treatment of cardiac ...

March 31, 2022

News | Heart Failure

Bone Marrow Contributes to the Development of Atherosclerosis

April 1, 2022 – The activation of the bone marrow appears to play a key role in the origin and development of ...

March 31, 2022

Sponsored Content

Patient applying a Cardiac Insight Cardea SOLO monitoring device at home. The remote, physician-prescribed and patient self-applied device is worn for a specified period of monitoring time and then returned to the physician office for report creation.

Feature | Atrial Fibrillation

Increasing Early Detection of Atrial Fibrillation Through Improved Short-Term Monitoring

Improved short-term monitoring methods for patients with stroke risk can increase early detection of atrial fibrillation ...

December 07, 2021

News | Population Health

Living Near Green Areas Reduces the Risk of Suffering a Stroke by 16%

April 1, 2022 – The risk of suffering an ischemic stroke, the most common type of cerebrovascular event, is 16% less in ...

March 31, 2022

The poster titled “Short term prediction of Atrial Fibrillation from ambulatory ECG using deep learning” presents results of a clinical study demonstrating that Cardiologs’ AI algorithm can predict the short-term risk of atrial fibrillation (AFib) based on single-lead Ambulatory electrocardiograms (ECGs) that show normal sinus rhythm.

News | Atrial Fibrillation

Cardiologs Announces Poster Presentation at ACC 2022

April 1, 2022 — Cardiologs announced a poster presentation at the 2022 American College of Cardiology (ACC) meeting in ...

April 01, 2022

Philips Ambient Experience with FlexVision display for pediatric patients

News | ACC

Philips Adds to its Cardiology Suite of Solutions at ACC 2022

April 1, 2022 — Royal Philips, a global leader in health technology, announced new additions to its innovative ...

April 01, 2022

Sponsored Content

Cardiovascular Ultrasound Analytics Aids Re-accreditation Process

Feature | Analytics Software

The Benefits of Data Analytics in Clinical Reporting

Accurate reporting is essential to producing the reliable analytics needed to meet lab accreditation standards. This is ...

October 27, 2021

News | ACC

Aidoc Showcases Full Cardiovascular AI Care Coordination Suite at ACC.22

March 31, 2022 – Healthcare AI solutions provider Aidoc will be delivering a live demonstration of its comprehensive AI ...

March 31, 2022

News | ACC

ACC Scientific Session 2022 to Feature Smidt Heart Institute Experts

March 31, 2022 – Experts from the Smidt Heart Institute at Cedars-Sinai, home to California’s top-ranked cardiology and ...

March 31, 2022

News | ACC

CathWorks Presents New Data and Latest Innovations at ACC 2022

March 31, 2022 – CathWorks has announced that the results of its most recent outcomes study on the CathWorks FFRangio ...

March 31, 2022

Sponsored Content

Feature | Cardiovascular Information Systems (CVIS)

Improving Consistency and Standardization With Structured Reporting

Jeff Rieder M.D., a cardiologist with Coastal Cardiology Charleston, clearly recalls the time when reporting was ...

July 26, 2021

In accordance with its commitment to patient safety, Medtronic recently voluntarily recalled a subset of its IN.PACT Admiral and IN.PACT AV Paclitaxel-coated Percutaneous Transluminal Angioplasty (PTA) balloon catheters due to the potential for pouch damage resulting in a loss of sterility.

News | Drug-Eluting Balloons

Medtronic Issues Voluntary Recall for Subset of IN.PACT Admiral and IN.PACT AV Drug Coated Balloon

March 31, 2022 — In accordance with its commitment to patient safety, Medtronic recently voluntarily recalled a subset ...

March 31, 2022

MedWatch, The FDA Safety Information and Adverse Event Reporting Program, announced that Pfizer is recalling Accuretic (quinapril hydrochloride/hydrochlorothiazide) tablets distributed by Pfizer as well as two authorized generics distributed by Greenstone (quinapril HCL and hydrochlorothiazide and quinapril HCl/hydrochlorothiazide) due to the presence of a nitrosamine, N-nitroso-quinapril, above the Acceptable Daily Intake level.

Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Top 10: Most Read Cardiology Content in March 2022

Here is what you and your colleagues found to be most interesting in the field of cardiology during the month of March ...

March 31, 2022

The annual congress of the European Heart Rhythm Association (EHRA), a branch of the ESC, will be held April 3-5 at the Bella Center in Copenhagen, Denmark and online. Explore the scientific program.

News | ESC

EHRA 2022: Cutting Edge Science in Heart Rhythm Disorders

March 31, 2022 — The annual congress of the European Heart Rhythm Association (EHRA), a branch of the ESC, will be held ...

March 31, 2022

Sponsored Content

Case Study | Cardiovascular Information Systems (CVIS)

Mining Cardiology Data to Optimize Patient Care and Improve Productivity

During the COVID-19 pandemic, many cardiology departments were faced with the daunting task of supporting inpatient and ...

June 18, 2021

Investigators from Cedars-Sinai have created an artificial intelligence-enabled tool that may make it easier to predict if a person will have a heart attack.

News | CT Angiography (CTA)

Artificial Intelligence Tool May Help Predict Heart Attacks

March 31, 2022 – Investigators from Cedars-Sinai have created an artificial intelligence-enabled tool that may make it ...

March 31, 2022

DiA Imaging Analysis Ltd, a leading global provider of AI-powered ultrasound analysis software, announced today a multi-year agreement with Change Healthcare, a global industry-leading provider of enterprise imaging solutions.

News | Cardiovascular Ultrasound

DiA Imaging Analysis Teams up with Healthcare Technology Company to Expand its AI Offering for Echo-lab Cardiac Exams

March 31, 2022 – DiA Imaging Analysis Ltd, a leading global provider of AI-powered ultrasound analysis software ...

March 31, 2022

Windtree Therapeutics, a biotechnology company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced it has successfully completed enrollment in its phase 2 study of istaroxime in early cardiogenic shock caused by heart failure.

News | Pharmaceuticals

Windtree Completes Enrollment of Phase 2 Study of Istaroxime in Early Cardiogenic Shock

March 31, 2022 – Windtree Therapeutics, a biotechnology company focused on advancing multiple late-stage interventions ...

March 31, 2022